These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The role of granulocyte-macrophage-colony stimulating factor, cortisol, and melatonin in the regulation of the circadian rhythms of peripheral blood cells in healthy volunteers and patients with breast cancer. Akbulut H; Icli F; Büyükcelik A; Akbulut KG; Demirci S J Pineal Res; 1999 Jan; 26(1):1-8. PubMed ID: 10102754 [TBL] [Abstract][Full Text] [Related]
4. Light exposure at night, urinary 6-sulfatoxymelatonin, and serum estrogens and androgens in postmenopausal Japanese women. Nagata C; Nagao Y; Yamamoto S; Shibuya C; Kashiki Y; Shimizu H Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1418-23. PubMed ID: 18559557 [TBL] [Abstract][Full Text] [Related]
5. Circadian rhythms of basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), insulin-like growth factor-1 (IGF-1), insulin-like growth factor binding protein-3 (IGFBP-3), cortisol, and melatonin in women with breast cancer. Haus E; Dumitriu L; Nicolau GY; Bologa S; Sackett-Lundeen L Chronobiol Int; 2001 Jul; 18(4):709-27. PubMed ID: 11587092 [TBL] [Abstract][Full Text] [Related]
6. Morning urinary assessment of nocturnal melatonin secretion in older women. Cook MR; Graham C; Kavet R; Stevens RG; Davis S; Kheifets L J Pineal Res; 2000 Jan; 28(1):41-7. PubMed ID: 10626600 [TBL] [Abstract][Full Text] [Related]
7. Individual variations in serum melatonin levels through time: implications for epidemiologic studies. Nogueira LM; Sampson JN; Chu LW; Yu K; Andriole G; Church T; Stanczyk FZ; Koshiol J; Hsing AW PLoS One; 2013; 8(12):e83208. PubMed ID: 24376664 [TBL] [Abstract][Full Text] [Related]
8. Plasma melatonin and the hormone-dependency of human breast cancer. Danforth DN; Tamarkin L; Mulvihill JJ; Bagley CS; Lippman ME J Clin Oncol; 1985 Jul; 3(7):941-8. PubMed ID: 4020407 [TBL] [Abstract][Full Text] [Related]
9. The effect of hormone therapy on serum melatonin concentrations in premenopausal and postmenopausal women: a randomized, double-blind, placebo-controlled study. Toffol E; Kalleinen N; Haukka J; Vakkuri O; Partonen T; Polo-Kantola P Maturitas; 2014 Apr; 77(4):361-9. PubMed ID: 24602553 [TBL] [Abstract][Full Text] [Related]
10. Serum sex hormone levels after menopause and subsequent breast cancer. Berrino F; Muti P; Micheli A; Bolelli G; Krogh V; Sciajno R; Pisani P; Panico S; Secreto G J Natl Cancer Inst; 1996 Mar; 88(5):291-6. PubMed ID: 8614008 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of melatonin and AFMK levels in women with breast cancer. de Castro TB; Bordin-Junior NA; de Almeida EA; de Campos Zuccari DAP Endocrine; 2018 Oct; 62(1):242-249. PubMed ID: 29797213 [TBL] [Abstract][Full Text] [Related]
12. Correlation between salivary and serum melatonin: dependence on serum melatonin levels. Laakso ML; Porkka-Heiskanen T; Alila A; Stenberg D; Johansson G J Pineal Res; 1990; 9(1):39-50. PubMed ID: 2231272 [TBL] [Abstract][Full Text] [Related]
13. Circadian disruption and breast cancer: from melatonin to clock genes. Stevens RG Epidemiology; 2005 Mar; 16(2):254-8. PubMed ID: 15703542 [TBL] [Abstract][Full Text] [Related]
14. Association of Circulating Progesterone With Breast Cancer Risk Among Postmenopausal Women. Trabert B; Bauer DC; Buist DSM; Cauley JA; Falk RT; Geczik AM; Gierach GL; Hada M; Hue TF; Lacey JV; LaCroix AZ; Tice JA; Xu X; Dallal CM; Brinton LA JAMA Netw Open; 2020 Apr; 3(4):e203645. PubMed ID: 32329771 [TBL] [Abstract][Full Text] [Related]
15. Urinary Melatonin in Relation to Postmenopausal Breast Cancer Risk According to Melatonin 1 Receptor Status. Devore EE; Warner ET; Eliassen AH; Brown SB; Beck AH; Hankinson SE; Schernhammer ES Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):413-419. PubMed ID: 28151704 [No Abstract] [Full Text] [Related]
16. Temporal reproducibility of taurine measurements in frozen serum of healthy postmenopausal women. Wójcik OP; Koenig KL; Zeleniuch-Jacquotte A; Costa M; Chen Y Br J Nutr; 2010 Sep; 104(5):629-32. PubMed ID: 20416131 [TBL] [Abstract][Full Text] [Related]
17. Recombinant cell ultrasensitive bioassay for measurement of estrogens in postmenopausal women. Wang S; Paris F; Sultan CS; Song RX; Demers LM; Sundaram B; Settlage J; Ohorodnik S; Santen RJ J Clin Endocrinol Metab; 2005 Mar; 90(3):1407-13. PubMed ID: 15572429 [TBL] [Abstract][Full Text] [Related]
18. Reproducibility over 5 years of measurements of 6-sulphatoxymelatonin in urine samples from postmenopausal women. Travis RC; Allen NE; Peeters PH; van Noord PA; Key TJ Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):806-8. PubMed ID: 12917214 [TBL] [Abstract][Full Text] [Related]